83 related articles for article (PubMed ID: 19795980)
1. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
2. Harmol used for the treatment of herpes simplex virus induced keratitis.
Xu H; Zhou N; Huang Z; Wu J; Qian Y
Virol J; 2024 May; 21(1):118. PubMed ID: 38802860
[TBL] [Abstract][Full Text] [Related]
3. Commercial human 3D corneal epithelial equivalents for modeling epithelial infection in herpes keratitis.
Borodianskiy-Shteinberg T; Bisht P; Das B; Kinchington PR; Goldstein RS
Virology; 2024 Jul; 595():110096. PubMed ID: 38710129
[TBL] [Abstract][Full Text] [Related]
4. Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.
Sarisky RT; Bacon T; Boon R; Locke L; Nguyen TT; Leary J; Esser K; Saltzman R
Antimicrob Agents Chemother; 2002 Sep; 46(9):2848-53. PubMed ID: 12183237
[TBL] [Abstract][Full Text] [Related]
5. Anti-herpetic Activity of
Castillo E; Duarte LF; Corrales N; Álvarez DM; Farías MA; Henríquez A; Smith PC; Agurto-Muñoz C; González PA
Front Microbiol; 2020; 11():2006. PubMed ID: 33013743
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
[TBL] [Abstract][Full Text] [Related]
7. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
[TBL] [Abstract][Full Text] [Related]
8. Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis.
Ren J; Antony F; Rouse BT; Suryawanshi A
Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986359
[TBL] [Abstract][Full Text] [Related]
9. Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA.
Wolff N; Kollenda S; Klein K; Loza K; Heggen M; Brochhagen L; Witzke O; Krawczyk A; Hilger I; Epple M
Nanoscale Adv; 2022 Oct; 4(21):4502-4516. PubMed ID: 36341304
[TBL] [Abstract][Full Text] [Related]
10. Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells.
Kalke K; Lund LM; Nyman MC; Levanova AA; Urtti A; Poranen MM; Hukkanen V; Paavilainen H
PLoS Pathog; 2022 Jul; 18(7):e1010688. PubMed ID: 35793357
[TBL] [Abstract][Full Text] [Related]
11. The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1.
Kalke K; Orpana J; Lasanen T; Esparta O; Lund LM; Frejborg F; Vuorinen T; Paavilainen H; Hukkanen V
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746761
[TBL] [Abstract][Full Text] [Related]
12. Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections.
Roy S; Sukla S; De A; Biswas S
Sci Rep; 2022 Jan; 12(1):1345. PubMed ID: 35079057
[TBL] [Abstract][Full Text] [Related]
13. Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.
Leal SM; Rodino KG; Fowler WC; Gilligan PH
Clin Microbiol Rev; 2021 Jun; 34(3):e0007019. PubMed ID: 34076493
[TBL] [Abstract][Full Text] [Related]
14. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
Kalke K; Lehtinen J; Gnjatovic J; Lund LM; Nyman MC; Paavilainen H; Orpana J; Lasanen T; Frejborg F; Levanova AA; Vuorinen T; Poranen MM; Hukkanen V
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322225
[TBL] [Abstract][Full Text] [Related]
15. Herpes Simplex Virus-1 infection in human primary corneal epithelial cells is blocked by a stapled peptide that targets processive DNA synthesis.
Guan H; Nuth M; Lee V; Lin C; Mitchell CH; Lu W; Scott RW; Parker MH; Kulp JL; Reitz AB; Ricciardi RP
Ocul Surf; 2021 Jan; 19():313-321. PubMed ID: 33161128
[TBL] [Abstract][Full Text] [Related]
16. Update on Herpes simplex keratitis management.
Sibley D; Larkin DFP
Eye (Lond); 2020 Dec; 34(12):2219-2226. PubMed ID: 32843744
[TBL] [Abstract][Full Text] [Related]
17.
Dhal U; Raju S; Singh AD; Mehta AC
J Thorac Dis; 2018 Nov; 10(11):6285-6297. PubMed ID: 30622804
[TBL] [Abstract][Full Text] [Related]
18. Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice.
Bernier KM; Morrison LA
Antiviral Res; 2018 Aug; 156():102-106. PubMed ID: 29908958
[TBL] [Abstract][Full Text] [Related]
19. Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility.
Brunnemann AK; Liermann K; Deinhardt-Emmer S; Maschkowitz G; Pohlmann A; Sodeik B; Fickenscher H; Sauerbrei A; Krumbholz A
Sci Rep; 2016 Jul; 6():29903. PubMed ID: 27426251
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
Sanchez MD; Ochoa AC; Foster TP
Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
